GRAS Notices
-
GRN No. 1090
Bifidobacterium bifidum strain NITE BP-31
Intended Use: | Intended for use as an ingredient in non-exempt infant formula for term infants at a level of 2.28 x 106 colony forming units/mL. |
---|---|
Basis: | Scientific procedures |
Notifier: | Meiji Co., Ltd. |
Notifier Address: |
1-29-1 Nanakuni, Hachiouji Tokyo 192-0919 Japan |
GRAS Notice (releasable information): | GRN 1090 with amendments (in PDF) (9.2 MB) |
Date of closure: | Apr 5, 2023 |
FDA's Letter: | FDA has no questions (in PDF) (209 kB) |
-